Core Viewpoint - HBN, a skincare brand, has submitted its application for a mainboard listing on the Hong Kong Stock Exchange, aiming to become the first stock representing "true efficacy skincare" in China and to leverage international capital markets for long-term development [1] Group 1: Company Overview - HBN was founded in 2019 with a commitment to the philosophy of "true efficacy" and a belief in the long-termism of "slow research" [2] - The brand has established itself among the top ten domestic skincare brands in China and is the largest domestic brand in the improvement skincare market [2] - HBN is recognized as a pioneer in the domestic retinol anti-aging sector and was one of the first brands to propose the "morning C, evening A" skincare concept [2] Group 2: Market Position and Performance - HBN's retinol and α-arbutin products have ranked first in sales in their categories for three consecutive years (2022-2024), creating a rare series of enduring bestsellers among domestic brands [2] - The company has accumulated over 4.6 million repeat customers, with average order values steadily increasing [3] - HBN's average repurchase rates on platforms like Tmall and Douyin are 35.4% and 44.0% respectively, significantly exceeding industry averages [3] Group 3: Financial Performance - HBN has experienced steady revenue growth, with total revenue reaching 2.08 billion yuan in 2024 and 1.51 billion yuan in the first three quarters of 2025, reflecting a year-on-year growth of 10.2% [4] - Adjusted net profit increased from 90 million yuan in 2023 to 130 million yuan in 2024, and further to 150 million yuan in the first three quarters of 2025 [4] - The adjusted net profit margin improved from 4.7% in 2023 to 6.2% in 2024, and reached 9.6% in the first three quarters of 2025, indicating a transition to a sustainable growth phase [4] Group 4: Research and Development - HBN has published 50 SCI-indexed papers, ranking first among domestic skincare brands for papers published as the first author [3] - The company ranks third among domestic brands in the number of new cosmetic raw materials registered by its own research and development as of September 2025 [3] - HBN has established a rigorous efficacy verification system and is the only skincare brand in China to conduct real-world efficacy testing for its entire product line through an international authority [3] Group 5: Future Outlook - HBN aims to establish a comprehensive multi-dimensional efficacy verification system throughout the product lifecycle, expanding verification from laboratories to real-world settings [4] - The company is promoting the establishment of industry standards for cosmetic efficacy evidence assessment, which is expected to lead to more standardized and transparent efficacy claims across the industry [4] - The upcoming listing in Hong Kong is seen as a critical step for HBN to transform its systematic research capabilities into broader market influence [5]

Core Viewpoint - Shenzhen HBN Technology (Group) Co., Ltd. is set to list on the Hong Kong Stock Exchange, aiming to become the first stock representing "true efficacy skincare" in China, showcasing a model of sustainable growth driven by systematic innovation in research and development [2][12]. Group 1: Company Overview - Founded in 2019, HBN adheres to the philosophy of "true efficacy" and believes in a long-term approach to research, focusing on building a healthy and sustainable brand development path [4]. - HBN has established itself among the top ten domestic skincare brands in China and is the largest domestic brand in the improvement skincare market, according to a report by ZhiShi Consulting [5]. Group 2: Market Position and Product Leadership - HBN has achieved a leading market position, particularly in the A-retinol anti-aging category, being one of the first domestic brands to propose the "morning C, evening A" skincare concept. Its A-retinol products have ranked first in sales for three consecutive years from 2022 to 2024 [7]. - The company has published 50 papers in SCI-indexed journals, ranking first among domestic skincare brands for first-author publications, demonstrating its strong research capabilities [8]. Group 3: User Trust and Financial Performance - HBN has accumulated over 4.6 million repeat customers, with average transaction values steadily increasing. The brand's average repurchase rates on platforms like Tmall and Douyin reached approximately 35.4% and 44.0% in 2025, significantly exceeding industry averages [10]. - The company reported a total revenue of 2.08 billion yuan in 2024, with a year-on-year growth of 10.2% in the first three quarters of 2025, and adjusted net profits increased from 90 million yuan in 2023 to 150 million yuan in the first three quarters of 2025 [10]. Group 4: Industry Growth and Future Potential - The skincare market in China is experiencing structural growth, with the top ten dermatological skincare brands projected to exceed 30 billion yuan in retail sales by 2024, reflecting a compound annual growth rate of over 16.7% from 2019 to 2024, outpacing the overall industry growth rate of approximately 8.6% [13]. - HBN is establishing a comprehensive efficacy verification system that spans the entire product lifecycle, aiming to enhance the credibility of efficacy claims and promote a more standardized approach within the industry [13][14].

Core Insights - The article discusses the emerging trend of "early C, late A" lifestyle among urban youth, leading to the growth of the restaurant and bar market in China, projected to reach a market size of 30.1 billion yuan in 2024 with a compound annual growth rate of 15.4% from 2025 to 2029 [2] Company Overview - COMMUNE, a restaurant and bar brand, was founded in 2016 and has rapidly expanded to 112 locations, recently filing for an IPO in Hong Kong [3][4] - The brand is recognized for its high efficiency and revenue per square meter, achieving a market share of 7.8% in the restaurant and bar sector, with revenues of 1 billion yuan [4] Business Model - COMMUNE operates on a "day restaurant, night bar" model, catering to different customer needs throughout the day, which helps reduce rental costs and improve space utilization [5][7] - The company has seen a significant increase in food sales, with the proportion of food revenue rising from 43.1% in 2023 to 54% in the first nine months of 2025, surpassing beverage sales for the first time [7] Financial Performance - The company reported revenues of 8.45 billion yuan in 2023, 10.74 billion yuan in 2024, and 8.72 billion yuan in the first nine months of 2025, with a consistent gross margin around 68% [7][12] - However, the adjusted net profit decreased from 73 million yuan in 2023 to 66 million yuan in 2024, indicating volatility in performance [12] Market Challenges - The growth in core markets appears to be plateauing, with same-store sales in first-tier cities declining from 2.12 billion yuan in 2023 to 1.99 billion yuan in 2025 [9][10] - The company's high-margin model faces challenges in lower-tier cities, where average daily sales are significantly lower compared to first-tier cities, indicating a need for tailored strategies [11][12] Cost Pressures - Rising costs of raw materials and labor are squeezing profit margins, with raw material costs increasing by 38.96% from 2023 to 2024 [12] - Employee benefits and labor costs also rose significantly, contributing to the overall pressure on profitability [12]

Core Viewpoint - In 2023, Proya surpassed L'Oreal on Tmall's Double 11 list, but after achieving over 10 billion in revenue, it faced significant declines in performance, with Q3 revenue down 11.63% and net profit down 23.64%, marking the largest quarterly drop in recent years [1][41] Company Performance - Proya's revenue for the first half of the year was 39.79 billion yuan, a slight decline of 0.08% year-on-year [1] - The company aims to enter the top ten global cosmetics brands within the next decade under the "Double 10 Strategy" initiated by the new general manager, Hou Yameng [1][41] - Proya's sales expenses reached 35.25 billion yuan in Q3 2025, accounting for 49.66% of revenue, a significant increase from the previous year [17][57] Market Positioning - Proya has been labeled as a "big brand alternative," often compared to L'Oreal, which has helped it penetrate the market but now poses challenges as it seeks to break through its brand ceiling [2][42] - The brand's product matrix follows a pyramid structure similar to L'Oreal, with a focus on mid-to-high-end efficacy skincare [5][45] Consumer Trends - The rise of domestic brands has been supported by a shift in consumer preferences towards value for money, with Proya's products priced between 200-500 yuan appealing to cost-conscious consumers [7][47] - Consumers are increasingly prioritizing product efficacy and ingredient safety over brand prestige, creating opportunities for Proya and other domestic brands [8][48] Challenges Faced - Proya is experiencing a decline in the effectiveness of its core products, with the market becoming saturated and competition intensifying [11][57] - The company's heavy reliance on marketing over research and development has led to a situation where marketing efforts are not translating into sustained product innovation [18][58] - Proya's online sales channel dependency exceeds 95%, limiting its ability to engage with consumers through offline experiences, which are increasingly valued by younger consumers [21][62] Global Expansion Efforts - Proya aims to expand internationally, focusing on markets in Japan and Southeast Asia, but its overseas revenue remains low at only 1.6% of total revenue [35][68] - The brand's high-end product lines and overseas operations are still in the early stages, lacking the scale and maturity of its mainstream offerings [28][68]

Core Viewpoint - Proya Cosmetics has submitted an IPO application to the Hong Kong Stock Exchange, aiming to become the largest domestic cosmetics group in China with a dual listing [6][7]. Group 1: Company Overview - Proya was founded in 2003 by Hou Junchen and his brother-in-law Fang Youyou, and has emerged as a leading domestic brand in the face of competition from international giants [6][13]. - The company achieved a revenue of 107.8 billion yuan in 2024, becoming the first domestic cosmetics brand to surpass the 100 billion yuan mark [6][18]. - Proya's stock price has increased from 15.3 yuan per share at its IPO in 2017 to around 70 yuan recently [7]. Group 2: Financial Performance - Proya's revenue from 2022 to 2025 is reported as follows: 63.85 billion yuan (2022), 89.05 billion yuan (2023), 107.78 billion yuan (2024), and 53.62 billion yuan in the first half of 2025 [18]. - The company's profit for the same periods was 8.31 billion yuan (2022), 12.31 billion yuan (2023), 15.85 billion yuan (2024), and 8.26 billion yuan in the first half of 2025 [18]. - However, in Q3 2025, Proya's revenue fell to 17.36 billion yuan, a year-on-year decrease of 11.63%, marking the lowest growth in five years [19]. Group 3: Strategic Initiatives - Proya has launched a mid-term dividend plan, proposing to distribute 8 yuan per 10 shares, totaling approximately 315 million yuan, which is the highest mid-term dividend ratio since its listing [6][18]. - The company is focusing on a "Double Ten Strategy" to enter the top ten global cosmetics companies within the next decade, with plans for acquisitions and international expansion [23]. - Proya is actively pursuing a dual listing in Hong Kong to enhance its international financing capabilities and support overseas market expansion [23]. Group 4: Market Position and Trends - Proya's online sales have surged, with online revenue accounting for 95.06% of total sales by 2024, reflecting a significant shift towards e-commerce [14][20]. - The company has adopted a "big single product strategy" to upgrade its product line, with successful products like the Ruby Essence and Dual Anti-Aging Essence [14][15]. - The brand has also positioned itself as a scientific skincare leader, investing heavily in R&D, with expenditures of 1.28 billion yuan, 1.74 billion yuan, and 2.1 billion yuan over recent years [15]. Group 5: Leadership Transition - The next generation of leadership is emerging, with Hou Junchen's son, Hou Yameng, taking over as general manager in September 2024, marking a significant transition for the company [22]. - The management changes and performance fluctuations have led to a decline in Proya's stock price, which has dropped over 13% since the beginning of the year [23].

Core Viewpoint - The article discusses the growth and strategic developments of Proya Cosmetics, highlighting its recent IPO application and significant financial milestones, including its entry into the "100 billion club" in revenue, and the introduction of a substantial dividend plan [5][13]. Group 1: Company Overview - Proya Cosmetics was founded in 2003 by Hou Junchen and his brother-in-law Fang Youyou, and has emerged as a leading domestic beauty brand in China [5][8]. - The company achieved a revenue of 107.8 billion yuan in 2024, becoming the first domestic beauty brand to surpass the 100 billion yuan mark [13]. - Proya's stock price has increased from 15.3 yuan per share at its IPO in 2017 to around 70 yuan recently [6]. Group 2: Business Strategy and Growth - Proya adopted a "rural encircling cities" strategy to differentiate itself from international brands, focusing on third and fourth-tier cities [8]. - The company successfully transitioned to e-commerce, with online sales accounting for 95.06% of its revenue by 2024 [9][15]. - Proya introduced a "big single product strategy" in 2020, focusing on high-demand products like the Ruby Essence and Dual Anti-Aging Essence, which align with the rising trend of ingredient-focused skincare [9][10]. Group 3: Financial Performance - Proya's revenue from 2022 to 2025 shows a growth trajectory with figures of 63.85 billion yuan, 89.05 billion yuan, and 107.78 billion yuan, but a decline is noted in 2025 with a revenue of 17.36 billion yuan in Q3, down 11.63% year-on-year [13][14]. - The main brand's growth has stagnated, with a slight decline of 0.08% in the first half of 2025, contrasting with previous growth rates of 37.46%, 36.36%, and 19.55% [13]. Group 4: Future Outlook and Leadership Transition - The company is entering a new era with the succession of Hou Junchen's son, Hou Yameng, who has been appointed as the general manager, indicating a shift towards a new generation of leadership [17]. - Proya aims to become one of the top ten global cosmetics companies within the next decade, with plans for international expansion and potential acquisitions [18]. - The company is actively pursuing an IPO on the Hong Kong Stock Exchange to enhance its international financing capabilities [18].

Core Viewpoint - Proya, a leading Chinese cosmetics company, is preparing for an IPO in Hong Kong, aiming to become the first A+H listed beauty brand, despite facing challenges such as declining performance and market value [1][2] Company Overview - Proya Cosmetics Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange, with CICC and UBS as joint sponsors [1] - The company was listed on the Shanghai Stock Exchange in November 2017, becoming the first domestic beauty stock [1] - Proya is currently the largest domestic cosmetics company in China and ranks fifth in the overall cosmetics market by retail sales [2][3] Financial Performance - Proya's revenue is projected to grow significantly, with estimates of approximately CNY 63.85 billion, CNY 89.05 billion, and CNY 107.78 billion from 2022 to 2024, respectively [3] - Net profit is also expected to rise from CNY 8.31 billion in 2022 to CNY 15.85 billion in 2024 [3] - However, in the first half of 2025, revenue growth slowed to 7.2%, with net profit increasing by 13.8%, marking the lowest growth rate in five years [3][5] Strategic Initiatives - Proya has implemented a "big single product" strategy, focusing on high-repurchase, high-user-engagement products, and a platform strategy to build a multi-brand matrix [2][3] - The company has successfully captured market trends through effective marketing strategies, including social media and live-streaming e-commerce [2] Market Dynamics - The Chinese cosmetics market is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2029, driven by the rise of domestic brands and changing consumer preferences [6][7] - Proya faces intense competition from both international giants and emerging domestic brands, necessitating a balance between marketing and research and development (R&D) [6][8] R&D and Marketing Expenditure - In the first half of 2025, Proya's sales and distribution expenses reached CNY 26.59 billion, accounting for 49.59% of total revenue, while R&D spending was only about CNY 95 million [7][8] - The company’s heavy reliance on marketing over R&D raises concerns about long-term sustainability and competitiveness in a rapidly evolving market [8] Investment Outlook - Proya is positioned well in the growing cosmetics market, benefiting from both industry trends and its operational capabilities [9] - However, challenges such as stagnant growth of the main brand and high sales expense ratios may impact profitability, warranting careful consideration from investors [9]

Core Viewpoint - Proya is initiating a Hong Kong listing to enhance its international strategy and overseas business development, aiming to increase its financing capabilities and support future global acquisitions [3][4]. Financial Performance - In the first three quarters of 2025, Proya achieved a revenue of 7.098 billion yuan, a year-on-year increase of 1.89%, and a net profit of 1.026 billion yuan, up 2.65% [3][4]. - The revenue for the first half of 2025 was 5.4 billion yuan, maintaining a leading position in the domestic beauty market [3][4]. - Proya's revenue growth from 2019 to 2024 was as follows: 32.28%, 20.13%, 23.47%, 37.82%, 39.45%, and 21.04% respectively, with net profit growth rates of 36.73%, 21.22%, 21.03%, 41.88%, 46.06%, and 30% [4]. Market Position and Competition - Proya is currently the leading domestic cosmetics brand, but faces increasing competition from brands like Maogeping, Shangmei, and others, making it challenging to maintain its market position [4][5]. - The phenomenon of Proya having the highest revenue but a declining stock price is attributed to concerns over its main brand's performance, leading to significant institutional investor withdrawals [3][4]. Research and Development Focus - Proya plans to use funds raised from the Hong Kong listing to enhance its R&D, brand building, and overseas market expansion [4][5]. - The company's R&D expenditure has been relatively low, hovering around 2%, with 2022 R&D expenses at 128 million yuan [4][5]. - Competitors like Huaxi Biological and Betaini have significantly higher R&D expenditure rates, indicating a potential area for Proya to improve [4][5].

Core Viewpoint - Proya is seeking to address its current challenges by initiating a Hong Kong listing to enhance its international strategy and financing capabilities, aiming to break through its slow growth and potential decline [1][3]. Financial Performance - In the first three quarters of 2025, Proya reported a revenue of 7.098 billion yuan, a year-on-year increase of 1.89%, and a net profit of 1.026 billion yuan, up 2.65% [3]. - However, there was a decline in revenue and net profit in the third quarter of 2025, with revenue and net profit decreasing by 11.63% and 23.64% respectively [4]. - The main brand Proya experienced a slight revenue decline of 0.08% in the first half of 2025, contrasting with a growth rate of 37.67% in the same period of 2024 [5]. Market Position - Proya leads the domestic cosmetics market with a revenue of 8.9 billion yuan in 2023, but faces increasing competition from emerging brands like Maogeping and Shangmei [8]. - Despite having the highest revenue, Proya's market capitalization is lower than that of competitors like Maogeping and Shangmei, indicating investor concerns about its future performance [6]. Strategic Initiatives - The company aims to use the funds raised from the Hong Kong listing to enhance its R&D, brand building, and overseas market expansion [9]. - Proya's R&D expenditure has been relatively low, with a rate around 2%, compared to competitors like Huaxi Biological and Beitaini, which have significantly higher R&D investment rates [9][10]. Future Outlook - Proya recognizes the importance of R&D for innovation and competitiveness, planning to strengthen its R&D capabilities through new centers in Shanghai and Hangzhou [11]. - The company is committed to a consumer-centric and technology-driven approach as it aims to solidify its position in the competitive landscape of the beauty industry [11].

Core Viewpoint - The article discusses the contrasting performance of Proya, a leading domestic beauty brand in China, highlighting its impressive sales during the Double Eleven shopping festival while facing significant stock price declines and slowing growth in recent financial results [1][3][5]. Group 1: Company Performance - Proya achieved over 1 billion yuan in sales within the first four hours of the Double Eleven pre-sale, becoming the top brand in the beauty category [1]. - Despite the sales success, Proya's stock price has dropped over 20% since May and more than 40% from its peak in 2023 [1]. - In the first half of 2025, Proya reported revenue of 5.362 billion yuan, a year-on-year increase of 7.21%, and a net profit of 799 million yuan, up 13.80% [5][6]. - The revenue growth rate of Proya in the first half of 2025 is the lowest since its listing in 2017, significantly down from 37.9% in the same period last year [6][9]. Group 2: Brand and Market Dynamics - Proya's main brand, which contributes nearly 80% of its revenue, saw a slight decline in revenue of 0.08% in the first half of 2025, marking its first negative growth in five years [10][11]. - The company has been expanding its multi-brand strategy through acquisitions, but the contributions from these new brands remain limited, with combined revenue from new brands being less than 1 billion yuan [14][16]. - The beauty market is becoming increasingly competitive, with mid-tier brands gaining market share while top brands like Proya are losing ground [24][25]. Group 3: Financial and Strategic Challenges - Proya's sales expenses reached 5.161 billion yuan in 2024, accounting for 47.88% of its revenue, while its R&D expenses were only 210 million yuan, indicating a heavy reliance on marketing over innovation [17]. - The company faces challenges in maintaining competitive product offerings, as it has not introduced new blockbuster products since its initial success [19]. - Proya's online sales accounted for over 95% of its revenue in 2024, highlighting its dependence on digital channels [33]. Group 4: Future Outlook - The article suggests that Proya is undervalued from an investment perspective, but it faces significant competition from both domestic and international brands [42]. - The company is undergoing leadership changes, which may introduce uncertainty into its operations [43]. - Proya must accelerate innovation and reform to realize its potential as a leading beauty brand in a rapidly evolving market [45].